1. "Meeting abstract"
  2. "David Hyman"
Formats
  1. Meeting Abstract (174)
Groups
  1. Department of Medicine (174)
  2. Early Drug Development Service (174)
  3. Solid Tumor Oncology Division (174)
  4. GSK Faculty (99)
  5. Human Oncology and Pathogenesis Program (99)
  6. Genitourinary Oncology Service (60)

More Groups

People
  1. David Hyman (174)
  2. Michael Berger (50)
  3. David Solit (49)
  4. Alexander Drilon (45)
  5. Ahmet Zehir (36)
  6. Marc Ladanyi (35)

More People

Years
  1. 2021 (1)
  2. 2020 (20)
  3. 2019 (44)
  4. 2018 (21)
  5. 2017 (23)
  6. 2016 (20)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Cancer Research (30)
  3. Blood (16)
  4. Annals of Oncology (14)
  5. Journal of Thoracic Oncology (6)
  6. Pediatric Blood and Cancer (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (68)
  2. American Association for Cancer Research (38)
  3. American Society of Hematology (16)
  4. Oxford University Press (16)
  5. Elsevier Inc. (11)
  6. Wiley Periodicals, Inc (6)

More Publishers

Results (174)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of erdafitinib in patients with advanced solid tumors and fibroblast growth factor receptor gene alterations
    Meeting Abstract

    Pant, S.; Tabernero, J.; Massard, C.; Hyman, D. M.; Witt, O.; Doi, T.; Qin, S.; Lu-Emerson, C.; Hargrave, D.; Garcia-Corbacho, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Immune and genomic profiling of small cell carcinomas of the ovary hypercalcemic type
    Meeting Abstract

    Dessources, K.; Holland, A.; Liu, J. D.; Lee, S. S.; Selenica, P.; Wu, M.; Stylianou, A.; Reis-Filho, J.; Hyman, D. M.; Hollmann, T. J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Community partnerships expand access to tumor molecular profiling
    Meeting Abstract

    Reynolds, T.; Jack, K.; Kemeny, M.; Bulone, L.; Gonsky, J.; Kampel, L. J.; Hyman, D.; Solit, D. B.; Conklin, C.; McMillan, S.; more...
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
    Meeting Abstract

    Leyvraz, S.; Berlin, J.; Hong, D. S.; Deeken, J.; Valentina, B.; Oh, D. Y.; Patel, J.; Nanda, S.; Brega, N.; Childs, B. H.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer
    Meeting Abstract

    Rubinstein, M. M.; Hyman, D.; Caird, I.; O'Cearbhaill, R.; Grisham, R.; Tew, W.; Hensley, M.; Sabbatini, P.; Aghajanian, C.; Iasonos, A.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • AKT mutant allele-specific activation dictates pharmacologic sensitivities
    Meeting Abstract

    Shrestha Bhattarai, T.; Shamu, T.; Patel, S.; Gorelick, A.; Chang, M. T.; Gavrila, E. I.; Gao, J. J.; Donoghue, M. T. A.; Gao, P. S.; Soumerai, T.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save